Bank of Montreal’s AstraZeneca AZN Stock Holding History

Bank of Montreal’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,000	Closed	-$68K	–	4163
2017 Q3	$68K	Sell	1,000 -86,700	-99%	-$5.48M	﹤0.01%	3118
2017 Q2	$5.98M	Buy	+87,700	New	+$5.73M	0.01%	1081
2015 Q1	–	Sell	-34,000	Closed	-$2.39M	–	3970
2014 Q4	$2.39M	Sell	34,000 -8,000	-19%	-$573K	﹤0.01%	1346
2014 Q3	$3M	Buy	+42,000	New	+$3.07M	﹤0.01%	1295

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Bank of Montreal's AZN Position: Q1 2026 in Review

Bank of Montreal increased its AstraZeneca (AZN) stake by 18% in Q1 2026, buying an estimated $55.4M and bringing the position to 1,926,315 shares worth $380M. The position accounts for 0.14% of the portfolio, ranked #130.

Bank of Montreal first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,381 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Bank of Montreal held 1,926,315 shares of AstraZeneca worth $380M as of Q1 2026.
Bank of Montreal bought 287,446 AstraZeneca shares in Q1 2026, an estimated $55.4M.
AstraZeneca made up 0.14% of Bank of Montreal's portfolio in Q1 2026, its #130 holding.
Bank of Montreal first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
1,381 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.